Challenges faced with fed-batch process; EnzeneX™ : The solution & future of biologics manufacturing

In this presentation at BIO 2024, our Chief Quality Officer, Sundar Ramanan, PhD, MBA highlights how Fully Connected Continuous Manufacturing outperforms fed-batch processes by offering uninterrupted processing from cell culture to the final drug substance. It maximizes resource efficiency, achieving a remarkable 10-fold increase in upstream productivity and a 25-50% improvement in downstream while eliminating multiple hold steps and transfers of in-process material. This approach enhances product quality through degradation minimization, enables reduction in emissions, and provides flexible design options for cost-effective manufacturing. Costs per gram can be slashed by up to 40%, making it a highly attractive option for biologics production.